Medigus Ltd. (NASDAQ:MDGS) (“Medigus”), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle (“EV”) and charging solutions, announced today that it plans to effect 1:15 ratio change of the Company’s American Depositary Receipt, or ADR, program. As a result, the number of ordinary shares of the Company represented by each American Depositary Share, or ADS, will be changed from one (1) ordinary share to fifteen (15) ordinary shares. The effective date anticipated for the ratio change is November 14, 2022 and the Company’s ADSs will continue to be traded on the Nasdaq Capital Market under the symbol “MDGS” with a new CUSIP Number 58471G 409.
Rite Aid Shares Plunge On Q2 Bottom-Line Miss, Warning On Consumer Spending & Supply Chain Challenges
Rite Aid Corp (NYSE:RAD) reported a second-quarter FY23 sales decline of 3.5% year-on-year to $5.90 billion, beating the consensus of $5.77…
